133 related articles for article (PubMed ID: 35822409)
1. SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma.
Feng S; Yuan W; Sun Z; Guo X; Ling J; Chang A; Zhao H; Zhuo X
J Oral Pathol Med; 2022 Aug; 51(7):620-629. PubMed ID: 35822409
[TBL] [Abstract][Full Text] [Related]
2. Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.
Brennan K; Espín-Pérez A; Chang S; Bedi N; Saumyaa S; Shin JH; Plevritis SK; Gevaert O; Sunwoo JB; Gentles AJ
Genome Med; 2023 Nov; 15(1):98. PubMed ID: 37978395
[TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
Zhao H; Ling J; Huang Y; Chang A; Zhuo X
J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
[TBL] [Abstract][Full Text] [Related]
4. TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher.
Lu T; Li Y; Pan M; Yu D; Wang Z; Liu C; Hu G
Int J Biol Sci; 2022; 18(5):1795-1812. PubMed ID: 35342354
[No Abstract] [Full Text] [Related]
5. The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.
Cai X; Zhang H; Li T
Int J Oral Maxillofac Surg; 2022 Jun; 51(6):732-741. PubMed ID: 34489157
[TBL] [Abstract][Full Text] [Related]
6. SPP1
Wu J; Shen Y; Zeng G; Liang Y; Liao G
Cancer Gene Ther; 2024 Feb; 31(2):311-321. PubMed ID: 38052857
[TBL] [Abstract][Full Text] [Related]
7. SPP1 is associated with adverse prognosis and predicts immunotherapy efficacy in penile cancer.
Zou Y; Tan X; Yuan G; Tang Y; Wang Y; Yang C; Luo S; Wu Z; Yao K
Hum Genomics; 2023 Dec; 17(1):116. PubMed ID: 38111044
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z
Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066
[TBL] [Abstract][Full Text] [Related]
9. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
Huang Y; Chang A; Zhou W; Zhao H; Zhuo X
Clin Exp Med; 2020 Nov; 20(4):515-525. PubMed ID: 32596748
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma.
Dong B; Wu C; Huang L; Qi Y
Front Cell Dev Biol; 2021; 9():739358. PubMed ID: 34646827
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
Kim HR; Moon JH; Lee JH; Lim YC
Ann Surg Oncol; 2021 Oct; 28(11):6479-6488. PubMed ID: 33783641
[TBL] [Abstract][Full Text] [Related]
12. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.
Bie T; Zhang X
J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
14. Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.
Xiang Z; Zhong C; Chang A; Ling J; Zhao H; Zhou W; Zhuo X
Aging (Albany NY); 2020 Feb; 12(3):2825-2839. PubMed ID: 32045884
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.
Zhang Y; Chen M; Liu Z; Wang X; Ji T
BMC Cancer; 2021 Nov; 21(1):1254. PubMed ID: 34800986
[TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
17. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune-related genes in the prognosis of head and neck cancer using a novel prognostic signature model.
Chang A; Wang Y; Guo X; Sun Z; Ling J; Pan J; Zhuo X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Oct; 136(4):478-489. PubMed ID: 37620228
[TBL] [Abstract][Full Text] [Related]
19. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
